Klimedix (Drospirenone, Estradiol Hemihydrate)

Drospirenone acts as a synthetic progestogen that blocks the luteinizing hormone surge, preventing ovulation, while also providing anti‑mineralocorticoid and anti‑androgenic effects. Estradiol supplies estrogenic activity that stabilises the endometrium and reinforces negative feedback on the hypothalamic‑pituitary‑ovarian axis, together creating an environment unsuitable for fertilisation and implantation.

The specific dosing regimen for Klimedix is determined by the prescribing healthcare professional. Typically, the medication is taken once daily at the same time each day, but the exact strength, tablet count and duration are set by the prescriber based on individual patient needs.

Klimedix is classified as Pregnancy Category X, meaning it is contraindicated in pregnancy because it may cause harm to the fetus. It is also not recommended for use while breastfeeding, as hormonal exposure could affect milk production and infant health. Alternative methods should be considered in these situations.

To order Klimedix, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Klimedix contains drospirenone, which has anti‑mineralocorticoid and anti‑androgenic properties not found in many other progestins, potentially offering benefits such as reduced water retention and improved acne. Its efficacy in preventing pregnancy is comparable to other combined pills, but individual tolerability and side‑effect profiles may differ.

Klimedix tablets should be stored at ambient temperature, below 25 °C, in the original blister pack or container. Protect them from excess moisture, heat and direct sunlight. Keep the medication out of reach of children and do not use after the expiry date printed on the packaging.

Klimedix is taken orally, usually as one tablet each day at the same time, without regard to meals. Consistent daily intake maintains hormone levels needed for contraceptive effectiveness. If a dose is missed, follow the specific instructions provided by the prescribing clinician or the product leaflet.

The most serious risks include venous thromboembolism (deep‑vein thrombosis or pulmonary embolism), arterial events such as stroke or myocardial infarction, and severe allergic reactions (anaphylaxis). Patients should seek immediate medical attention if they experience unexplained leg pain, sudden shortness of breath, severe headache, visual changes, or signs of an allergic reaction.

Klimedix should not be used by women who are pregnant, have a known or suspected pregnancy, have a history of thromboembolic disorders, uncontrolled hypertension, severe liver disease, or are smokers over the age of 35. It is also contraindicated in individuals with known hypersensitivity to drospirenone, estradiol or any excipients in the tablet.